Torin1
CAS No. 1222998-36-8
Torin1( Torin 1 | Torin-1 )
Catalog No. M10848 CAS No. 1222998-36-8
Torin1 is a highly potent, selective inhibitor of mTORC1 and mTORC2 with IC50 of 2 and 10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 60 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 447 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTorin1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTorin1 is a highly potent, selective inhibitor of mTORC1 and mTORC2 with IC50 of 2 and 10 nM.
-
DescriptionTorin1 is a highly potent, selective inhibitor of mTORC1 and mTORC2 with IC50 of 2 and 10 nM in cell-free assays, exhibits 1,000-fold selectivity PI3K (EC50=1,800 nM); exhibits 100-fold binding selectivity relative to 450 other protein kinases; causes cell cycle arrest through a rapamycin-resistant mechanism that is also independent of mTORC2, disrupts mTORC1-dependent phenotypes more completely than rapamycin; prevents the anti-inflammatory potency of GC both in human monocytes and myeloid dendritic cells.(In Vitro):Torin1 (250 nM) completely inhibits proliferation and causes a G1/S cell cycle arrest, and decreases cell size to a greater degree than 50 nM rapamycin in wild-type MEFs. Torin1 has more than 800-fold selectivity between mTOR and PI3Kis, and is very selective relative to other PIKK family kinases with the exception of DNA-PK.(In Vivo):Torin1 (20 mg/kg, i.p.) is efficacious in a U87MG xenograft model, and demonstrates good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues.
-
In VitroTorin1 (250 nM) completely inhibits proliferation and causes a G1/S cell cycle arrest, and decreases cell size to a greater degree than 50 nM rapamycin in wild-type MEFs. Torin1 has more than 800-fold selectivity between mTOR and PI3Kis, and is very selective relative to other PIKK family kinases with the exception of DNA-PK.
-
In VivoTorin1 (20 mg/kg, i.p.) is efficacious in a U87MG xenograft model, and demonstrates good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues.
-
SynonymsTorin 1 | Torin-1
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptorDNA-PK|mTOR|mTORC1|mTORC2|p110γ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1222998-36-8
-
Formula Weight607.6243
-
Molecular FormulaC35H28F3N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 6.6 mg/mL (Need ultrasonic or warming)
-
SMILESO=C1N(C2=CC=C(N3CCN(C(CC)=O)CC3)C(C(F)(F)F)=C2)C4=C(C=NC5=CC=C(C6=CC7=CC=CC=C7N=C6)C=C54)C=C1
-
Chemical NameBenzo[h]-1,6-naphthyridin-2(1H)-one, 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thoreen CC, et al. J Biol Chem. 2009 Mar 20;284(12):8023-32.
2. Liu Q, et al. J Med Chem. 2010 Oct 14;53(19):7146-55.
3. Weichhart T, et al. Blood. 2011 Apr 21;117(16):4273-83.
4. Thoreen CC, et al. Autophagy. 2009 Jul;5(5):725-6.
molnova catalog
related products
-
CZC-25146
CZC-25146 is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively.
-
Seco Rapamycin
Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR.
-
WYE-125132
A potent, specific, ATP-competitive and orally active mTOR inhibitor with IC50 of 0.19 nM.
Cart
sales@molnova.com